Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2

Status

Not yet recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 45Neoplasms 26Colorectal Neoplasms 24Neoplasm Metastasis 22Recurrence 21Ovarian Neoplasms 21Pancreatic Neoplasms 20Breast Neoplasms 19Squamous Cell Carcinoma of Head and Neck 17Melanoma 16Glioblastoma 15Prostatic Neoplasms 14Lymphoma, Large B-Cell, Diffuse 13Endometrial Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Multiple Myeloma 12Lymphoma, Non-Hodgkin 12Triple Negative Breast Neoplasms 11Lung Neoplasms 11Glioma 10Colonic Neoplasms 10Carcinoma, Renal Cell 10Stomach Neoplasms 9Rectal Neoplasms 9Gastrointestinal Neoplasms 9Lymphoma, Follicular 8Lymphoma 8Leukemia, Myeloid, Acute 8Head and Neck Neoplasms 8Brain Neoplasms 8

Interventions

sintilimab 1osimertinib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Solid Tumor × 30 days × Clear all
NCT07623707 2026-06-03

A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

FutureGen Biopharmaceutical (Beijing) Co., Ltd

Phase 1/2 Not yet recruiting
264 enrolled
Other solid neoplasm

Solid Tumor

NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1/2 Not yet recruiting
282 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡